SESN

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer
Welcome back to another busy day of trading as we break down the biggest pre-market stock movers investors need to know about for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer
Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday!

6 of the Best Penny Stocks Under $1 to Buy Now for 2022

By Thomas Niel, InvestorPlace Contributor
These penny stocks trading for under $1 per share all have strong chances of delivering stunning returns in the coming year.

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts

By Thomas Niel, InvestorPlace Contributor
These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.

7 Penny Stocks with 10x Potential in 2022

By Thomas Niel, InvestorPlace Contributor
Which penny stocks should you watch into 2022? Keep these early-stage companies, fallen angels and turnaround plays on your radar.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer
Welcome back, trader! We're kicking off another busy week of trading with lists of the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer
Good morning, investor! We're getting right into the swing of things today with a look at the biggest pre-market stock movers for Thursday!

SESN News: Why Biotech Penny Stock Sesen Bio Is Skryocketing Today

By William White, InvestorPlace Writer
Sesen Bio (SESN) stock is rising higher on Wednesday after revealing plans to meet with the U.S. Food and Drug Administration.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer
I hope you're ready for another busy day of trading because we're starting it with the biggest pre-market stock movers for Wednesday.

3 Penny Stocks Waiting on FDA Approval for Rocket Fuel

By Faizan Farooque, InvestorPlace Contributor
Several penny stocks out there have done very well recently but these three biotechs are waiting for positive FDA news to soar higher.

Sesen’s Last Remaining Hope Is a Short Squeeze

By Ian Bezek, InvestorPlace Contributor
Sesen has cash and some short squeeze potential. But with its lead drug facing regulatory setbacks, SESN stock is a gamble at best.

7 Penny Stocks Waiting on the FDA for Rocket Fuel

By Thomas Niel, InvestorPlace Contributor
News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks.

Sesen Bio Got Slammed, but There’s Hope on the Horizon

By Louis Navellier and the InvestorPlace Research Staff
Despite a bump in the road for Sesen Bio, the story isn't fully written yet and a now-cheaper SESN stock price could be an opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer
Good morning, trader! We're back at it once again with another update on the biggest pre-market stock movers for Thursday.

SESN Stock: Why Sesen Bio Is Getting Slammed Today

By William White, InvestorPlace Writer
Sesen Bio (SESN) stock is taking a beating on Monday following a letter from the U.S. Food and Drug Administration (FDA).

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer
Good morning, investor! It's been a while but we're back at it with a look at the biggest pre-market stock movers for Monday.

What Did the Stock Market Do Today, Aug. 13? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
So what did the stock market do today? All eyes were on a wacky story about GRNV stock, a little-known SPAC that skyrocketed.

SESN Stock: The Painful FDA Blow That Has Sesen Bio Plunging Today

By Brenden Rearick, InvestorPlace Financial News Writer
SESN stock is plummeting today. The company was unexpectedly denied approval for its bladder cancer-treatment drug, disappointing investors.

Dear SESN Stock Fans, Mark Your Calendars for August 18

By Chris MacDonald, InvestorPlace Contributor
Today, a key upcoming decision on Aug. 18 is driving investors to consider SESN stock today, a major player in the bladder cancer space.
Load More